{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T04:31:59Z","timestamp":1786422719590,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004035","name":"Jordan University of Science and Technology","doi-asserted-by":"publisher","award":["20210327"],"award-info":[{"award-number":["20210327"]}],"id":[{"id":"10.13039\/501100004035","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.cca.2026.121133","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T23:19:38Z","timestamp":1780355978000},"page":"121133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Influence of NAT2 genetic variability on glycemic control in type 2 diabetes"],"prefix":"10.1016","volume":"591","author":[{"given":"Nosayba","family":"Al-Azzam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rawan","family":"Al-Reshiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Elsalem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balqis M.","family":"Abu Mousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khawla","family":"Mhedat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaineh","family":"Alfreahat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesreen","family":"Saadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.cca.2026.121133_bb0005","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.2337\/dc22-S002","article-title":"2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022","volume":"45","author":"American Diabetes Association Professional Practice C","year":"2022","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.cca.2026.121133_bb0010","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJMoa021778","article-title":"Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes","volume":"348","author":"Gaede","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"9733","key":"10.1016\/j.cca.2026.121133_bb0015","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"375","author":"Emerging Risk Factors C","year":"2010","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.cca.2026.121133_bb0020","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s00125-022-05713-6","article-title":"Low- and middle-income countries demonstrate rapid growth of type 2 diabetes: an analysis based on global burden of disease 1990-2019 data","volume":"65","author":"Liu","year":"2022","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.cca.2026.121133_bb0025","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2991\/jegh.k.191028.001","article-title":"Epidemiology of type 2 diabetes - global burden of disease and forecasted trends","volume":"10","author":"Khan","year":"2020","journal-title":"J. Epidemiol. Glob. Health"},{"key":"10.1016\/j.cca.2026.121133_bb0030","unstructured":"Federation ID. IDF Diabetes Atlas (11th edition): Jordan Country Report [Country reports]. Brussels, Belgium2024 [Available from: https:\/\/idf.org\/our-network\/regions-and-members\/middle-east-and-north-africa\/members\/jordan\/."},{"issue":"1","key":"10.1016\/j.cca.2026.121133_bb0035","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1152\/physrev.00008.2017","article-title":"Pancreatic beta-cell electrical activity and insulin secretion: of mice and men","volume":"98","author":"Rorsman","year":"2018","journal-title":"Physiol. Rev."},{"issue":"9","key":"10.1016\/j.cca.2026.121133_bb0040","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s00424-020-02417-x","article-title":"Glucose transporters in adipose tissue, liver, and skeletal muscle in metabolic health and disease","volume":"472","author":"Chadt","year":"2020","journal-title":"Pflugers Arch."},{"issue":"8","key":"10.1016\/j.cca.2026.121133_bb0045","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1080\/00325481.2020.1771047","article-title":"Beta-cell failure in type 2 diabetes: mechanisms, markers, and clinical implications","volume":"132","author":"Wysham","year":"2020","journal-title":"Postgrad. Med."},{"issue":"1","key":"10.1016\/j.cca.2026.121133_bb0050","doi-asserted-by":"crossref","first-page":"50","DOI":"10.15420\/ecr.2018.33.1","article-title":"The role of inflammation in diabetes: current concepts and future perspectives","volume":"14","author":"Tsalamandris","year":"2019","journal-title":"Eur Cardiol."},{"key":"10.1016\/j.cca.2026.121133_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2019.11.051","article-title":"Role of gut microbiota in type 2 diabetes pathophysiology","volume":"51","author":"Gurung","year":"2020","journal-title":"EBioMedicine"},{"issue":"9","key":"10.1016\/j.cca.2026.121133_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006958","article-title":"Intestinal microbiota regulate xenobiotic metabolism in the liver","volume":"4","author":"Bjorkholm","year":"2009","journal-title":"PloS One"},{"key":"10.1016\/j.cca.2026.121133_bb0065","doi-asserted-by":"crossref","first-page":"896","DOI":"10.3389\/fphys.2018.00896","article-title":"Sources of inter-individual variability in the therapeutic response of blood glucose control to exercise in type 2 diabetes: going beyond exercise dose","volume":"9","author":"Solomon","year":"2018","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.cca.2026.121133_bb0070","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00125-024-06254-w","article-title":"Glycaemic control is still central in the hierarchy of priorities in type 2 diabetes management","volume":"68","author":"Khunti","year":"2025","journal-title":"Diabetologia"},{"key":"10.1016\/j.cca.2026.121133_bb0075","article-title":"Understanding your A1C test [internet]","author":"ADA","year":"2022","journal-title":"American Diabetes Association"},{"issue":"1","key":"10.1016\/j.cca.2026.121133_bb0080","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12902-022-00974-z","article-title":"Evaluation of glycemic control and related factors among outpatients with type 2 diabetes at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia: a cross-sectional study","volume":"22","author":"Abera","year":"2022","journal-title":"BMC Endocr. Disord."},{"issue":"9","key":"10.1016\/j.cca.2026.121133_bb0085","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1038\/s41588-023-01462-3","article-title":"GWAS of random glucose in 476,326 individuals provide insights into diabetes pathophysiology, complications and treatment stratification","volume":"55","author":"Lagou","year":"2023","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.cca.2026.121133_bb0090","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12929-025-01137-7","article-title":"Exploring the genomic and transcriptomic profiles of glycemic traits and drug repurposing","volume":"32","author":"Lin","year":"2025","journal-title":"J. Biomed. Sci."},{"issue":"4","key":"10.1016\/j.cca.2026.121133_bb0095","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/jdi.13970","article-title":"Progress in genetics of type 2 diabetes and diabetic complications","volume":"14","author":"Shojima","year":"2023","journal-title":"J Diabetes Investig."},{"issue":"4","key":"10.1016\/j.cca.2026.121133_bb0100","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.arcmed.2011.06.007","article-title":"Association of NAT2 polymorphisms with type 2 diabetes in a population from Bosnia and Herzegovina","volume":"42","author":"Semiz","year":"2011","journal-title":"Arch. Med. Res."},{"issue":"4","key":"10.1016\/j.cca.2026.121133_bb0105","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/cbf.1314","article-title":"N-acetyltransferase 2 polymorphism in patients with diabetes mellitus","volume":"25","author":"Yalin","year":"2007","journal-title":"Cell Biochem. Funct."},{"issue":"4","key":"10.1016\/j.cca.2026.121133_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0283726","article-title":"NAT2 global landscape: genetic diversity and acetylation statuses from a systematic review","volume":"18","author":"Gutierrez-Virgen","year":"2023","journal-title":"PLoS One"},{"issue":"30","key":"10.1016\/j.cca.2026.121133_bb0115","doi-asserted-by":"crossref","first-page":"33045","DOI":"10.1021\/acsomega.5c02316","article-title":"Residue variations in human N-acetyltransferase 2 enzyme alleles: from rapid to slow acetylation","volume":"10","author":"Veldman","year":"2025","journal-title":"ACS Omega"},{"issue":"5","key":"10.1016\/j.cca.2026.121133_bb0120","doi-asserted-by":"crossref","first-page":"542","DOI":"10.4103\/0971-5916.187101","article-title":"NAT2 gene polymorphism: covert drug interaction causing phenytoin toxicity","volume":"143","author":"Adithan","year":"2016","journal-title":"Indian J. Med. Res."},{"issue":"2","key":"10.1016\/j.cca.2026.121133_bb0125","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.lungcan.2010.12.012","article-title":"NAT2 polymorphism and lung cancer risk: a meta-analysis","volume":"73","author":"Cui","year":"2011","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cca.2026.121133_bb0130","article-title":"Function and expression of N-acetyltransferases 1 and 2 are altered in lymphocytes in type 2 diabetes and obesity","volume":"38","author":"Paz-Rodriguez","year":"2024","journal-title":"Biochem. Biophys. Rep."},{"issue":"4","key":"10.1016\/j.cca.2026.121133_bb0135","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1172\/JCI74692","article-title":"Identification and validation of N-acetyltransferase 2 as an insulin sensitivity gene","volume":"125","author":"Knowles","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2026.121133_bb0140","first-page":"847","article-title":"Clinical significance of NAT2 genetic variations in type II diabetes mellitus and lipid regulation","volume":"16","author":"Jarrar","year":"2023","journal-title":"Pharmgenomics Pers. Med."},{"issue":"3","key":"10.1016\/j.cca.2026.121133_bb0145","doi-asserted-by":"crossref","first-page":"214","DOI":"10.5144\/0256-4947.2015.214","article-title":"N-acetyltransferase 1 and 2 polymorphisms and risk of diabetes mellitus type 2 in a Saudi population","volume":"35","author":"Al-Shaqha","year":"2015","journal-title":"Ann. Saudi Med."},{"issue":"7","key":"10.1016\/j.cca.2026.121133_bb0150","article-title":"N-acetyltransferase-2 genotypes among Jordanian patients with diabetes mellitus","volume":"51","author":"Irshaid","year":"2013","journal-title":"International journal of Clin. Pharmacol. Ther. (St. Louis, MO, U. S.)"},{"issue":"6","key":"10.1016\/j.cca.2026.121133_bb0155","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1002\/cpt.70071","article-title":"Clinical pharmacogenetics implementation consortium guideline for NAT2 genotype and hydralazine therapy","volume":"118","author":"Eadon","year":"2025","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.cca.2026.121133_bb0160","doi-asserted-by":"crossref","DOI":"10.1590\/0074-02760210328","article-title":"Homozygotes NAT2*5B slow acetylators are highly associated with hepatotoxicity induced by anti-tuberculosis drugs","volume":"117","author":"El-Jaick","year":"2022","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"4","key":"10.1016\/j.cca.2026.121133_bb0165","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4236\/ojgen.2012.24028","article-title":"N-acetyltransferase 2: slow, intermediate or fast? A booming question of the molecular epidemiology in cancer research","volume":"2","author":"Di Pietro","year":"2012","journal-title":"Open Journal of Genetics."},{"issue":"11","key":"10.1016\/j.cca.2026.121133_bb0170","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1111\/bph.12598","article-title":"Arylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discovery","volume":"171","author":"Sim","year":"2014","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.cca.2026.121133_bb0175","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s12291-010-0055-5","article-title":"Acetylation pharmacogenetics and renal function in diabetes mellitus patients","volume":"25","author":"Banjoko","year":"2010","journal-title":"Indian J. Clin. Biochem."},{"key":"10.1016\/j.cca.2026.121133_bb0180","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2156-6-30","article-title":"Inferring haplotypes at the NAT2 locus: the computational approach","volume":"6","author":"Sabbagh","year":"2005","journal-title":"BMC Genet."},{"issue":"1","key":"10.1016\/j.cca.2026.121133_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/hgv.2014.14","article-title":"NAT2 genetic variations among south Indian populations","volume":"1","author":"Lakkakula","year":"2014","journal-title":"Human Genome Variation."},{"issue":"1","key":"10.1016\/j.cca.2026.121133_bb0190","doi-asserted-by":"crossref","first-page":"1408381","DOI":"10.1080\/19932820.2017.1408381","article-title":"Sequence analysis of the N-acetyltransferase 2 gene (NAT2) among Jordanian volunteers","volume":"13","author":"Jarrar","year":"2018","journal-title":"Libyan J Med."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126003153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126003153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T04:20:52Z","timestamp":1786422052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898126003153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":38,"alternative-id":["S0009898126003153"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2026.121133","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of NAT2 genetic variability on glycemic control in type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2026.121133","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"121133"}}